The potential for estrogens in preventing Alzheimer's disease and vascular dementia

Therapeutic Advances in Neurological Disorders

Volumn 2, Issue 1, 2009, Pages 31-49

  Simpkins, James W ^a   Perez, Evelyn ^a   Wang, Xiaofei ^a   Yang, Shaohua ^a   Wen, Yi ^a   Singh, Meharvan ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Alzheimer's disease; Estradiol; Estrogens; Memory and cognition; Neurodegeneration

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; MEDROXYPROGESTERONE ACETATE; TAU PROTEIN;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; CELL DEATH; DRUG ACTIVITY; ESTROGEN ACTIVITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MITOSIS; MULTIINFARCT DEMENTIA; NERVE CELL; NEUROPROTECTION; NONHUMAN; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SINGLE DRUG DOSE;

EID: 77953468577     PISSN: 17562856     EISSN: None     Source Type: Journal    
DOI: 10.1177/1756285608100427     Document Type: Review

References (234)

1. Aisen, P., Albert, M., Breitner, J.C.S., Buckholtz, N., Corey-Bloom, J.P., Cummings, J.L. et al. (2008) Preventing dementia: following in Leon Thal's footsteps, Alzheimer's Dementia 4: 156-163.
2. Alkayed, N.J., Harukuni, I., Kimes, A.S., London, E.D., Traystman, R.J. and Hurn, P.D. (1998) Gender-linked brain injury in experimental stroke, Stroke 29: 159-165.
3. Altieri, M., Di Piero, V., Pasquini, M., Gasparini, M., Vanacore, N., Vicenzini, E. et al. (2004) Delayed poststroke dementia: a 4-year follow-up study, Neurology 62: 2193-2197.
4. Anderson, G.L., Limacher, M., Assaf, A.R., Bassford, T., Beresford, S.A., Black, H. et al. (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial, JAMA 291: 1701-1712.
5. Ayres, S., Tang, M. and Subbiah, M.T. (1996) Estradiol-17beta as an antioxidant: some distinct features when compared with common fat-soluble antioxidants, J Lab Clin Med 128: 367-375.
6. Ba, F., Pang, P.K. and Benishin, C.G. (2004) The role of Ca2+ channel modulation in the neuroprotective actions of estrogen in beta-amyloid protein and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) cytotoxic models, Neurochem Int 45: 31-38.
7. Bae, Y.H., Hwang, J.Y., Kim, Y.H. and Koh, J.Y. (2000) Anti-oxidative neuroprotection by estrogens in mouse cortical cultures, J Korean Med Sci 15: 327- 336.
8. Bagetta, G., Chiappetta, O., Amantea, D., Iannone, M., Rotiroti, D., Costa, A. et al. (2004) Estradiol reduces cytochrome c translocation and minimizes hippocampal damage caused by transient global ischemia in rat, Neurosci Lett 368: 87-91.
9. Bayir, H., Marion, D.W., Puccio, A.M., Wisniewski, S.R., Janesko, K.L., Clark, R.S. and Kochanek, P.M. (2004) Marked gender effect on lipid peroxidation after severe traumatic brain injury in adult patients, J Neurotrauma 21: 1-8.
10. Bederson, J.B., Pitts, L.H., Tsuji, M., Nishimura, M.C., Davis, R.L. and Bartkowski, H. (1986) Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination, Stroke 17: 472-476.
11. Behl, C., Widmann, M., Trapp, T. and Holsboer, F. (1995) 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro, Biochem Biophys Res Commun 216: 473-482.
12. Behl, C., Skutella, T., Lezoualc'h, F., Post, A., Widmann, M., Newton, C.J. et al. (1997) Neuroprotection against oxidative stress by estrogens: structure-activity relationship, Mol Pharmacol 51: 535-541.
13. Berco, M. and Bhavnani, B.R. (2001) Differential neuroprotective effects of equine estrogens against oxidized low density lipoprotein-induced neuronal cell death, J Soc Gynecol Investig 8: 245-254.
14. Bettini, E. and Maggi, A. (1992) Estrogen induction of cytochrome c oxidase subunit III in rat hippocampus, J Neurochem 58: 1923-1929.
15. Bhavnani, B.R., Cecutti, A., Gerulath, A., Woolever, A.C. and Berco, M. (2001) Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women, Menopause 8: 408-419.
16. Biewenga, E., Cabell, L. and Audesirk, T. (2005) Estradiol and raloxifene protect cultured SN 4741 neurons against oxidative stress, Neurosci Lett 373: 179-183.
17. Bishop, J. and Simpkins, J.W. (1994) Estradiol treatment increases viability of glioma and neuroblastoma cells in vitro, Mol Cell Neurosci 5: 303-308.
18. Blum-Degen, D., Haas, M., Pohli, S., Harth, R., Roömer, W., Oettel, M. et al. (1998) Scavestrogens protect IMR 32 cells from oxidative stress-induced cell death, Toxicol Appl Pharmacol 152: 49-55.
19. Bonnefont, A.B., Munoz, F.J. and Inestrosa, N.C. (1998) Estrogen protects neuronal cells from the cytotoxicity induced by acetylcholinesterase-amyloid complexes, FEBS Lett 441: 220-224.
20. Bornstein, N.M., Gur, A.Y., Treves, T.A., Reider-Groswasser, I., Aronovich, B.D., Klimovitzky, S.S. et al. (1996) Do silent brain infarctions predict the development of dementia after first ischemic stroke? Stroke 27: 904-905.
21. Brinton, R.D., Chen, S., Montoya, M., Hsieh, D. and Minaya, J. (2000) The estrogen replacement therapy of theWomen's Health Initiative promotes the cellular mechanisms of memory and neuronal survival in neurons vulnerable to Alzheimer's disease, Maturitas 34(Suppl. 2): S35-S52.
22. Brinton, R.D. (2004) Requirements of a brain selective estrogen: advances and remaining challenges for developing a NeuroSERM, J Alzheimers Dis 6(Suppl. 6): S27-S35
23. Brooke, S.M. and Sapolsky, R.M. (2000) The effects of steroid hormones in HIV-related neurotoxicity: a mini review, Biol Psychiatry 48: 881-893.
24. Bruce-Keller, A.J., Barger, S.W., Moss, N., Pham, J.T., Keller, J.N. and Nath, A. (2001) Pro-inflammatory and pro-oxidant properties of the HIV protein Tat in a microglial cell line: attenuation by 17 beta-estradiol, J Neurochem 78: 1315-1324.
25. Bruce-Keller, A.J., Keeling, J.L., Keller, J.N., Huang, F.F., Camondola, S. and Mattson, M.P. (2000) Antiinflammatory effects of estrogen on microglial activation, Endocrinology 141: 3646-3656.
26. Carlson, L.E. and Sherwin, B.B. (1998) Steroid hormones, memory and mood in a healthy elderly population [In Process Citation], Psychoneuroendocrinology 23: 583-603.
27. Carroll, J.C., Rosario, E.R., Chang, L., Stanczyk, F.Z., Oddo, S., LaFerla, F.M. and Pike, C.J. (2007) Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice, J Neurosci 27: 13357-65.
28. Carswell, H.V., Dominiczak, A.F. and Macrae, I.M. (2000) Estrogen status affects sensitivity to focal cerebral ischemia in stroke-prone spontaneously hypertensive rats, Am J Physiol Heart Circ Physiol 278: H290-H294.
29. Chae, H.S., Bach, J.H., Lee, M.W., Kim, H.S., Kim, Y.S., Kim, K.Y. et al. (2001) Estrogen attenuates cell death induced by carboxy-terminal fragment of amyloid precursorprotein in PC 12 through a receptor-dependent pathway, J Neurosci Res 65: 403-407.
30. Chang, D., Kwan, J. and Timiras, P.S. (1997) Estrogens influence growth, maturation, and amyloid beta-peptide production in neuroblastoma cells and in a beta-APP transfected kidney 293 cell line, Adv Exp Med Biol 429: 261-271.
31. Chen, J., Delannoy, M., Odwin, S., He, P., Trush, M.A. and Yager, J.D. (2003) Enhanced mitochondrial gene transcript, ATP, bcl-2 protein levels, and altered glutathione distribution in ethinyl estradiol-treated cultured female rat hepatocytes, Toxicol Sci 75: 271-278.
32. Chen, J.Q., Eshete, M., Alworth, W.L. and Yager, J.D. (2004 a) Binding of MCF-7 cell mitochondrial proteins and recombinant human estrogen receptors alpha and beta to human mitochondrial DNA estrogen response elements, J Cell Biochem 93: 358-373.
33. Chen, J.Q., Delannoy, M., Cooke, C. and Yager, J.D. (2004 b) Mitochondrial localization of ERalpha and ERbeta in human MCF 7 cells, Am J Physiol Endocrinol Metab 286: E1011-E1022.
34. Chen, J.Q. and Yager, J.D. (2004) Estrogen's effects on mitochondrial gene expression: mechanisms and potential contributions to estrogen carcinogenesis, Ann N Y Acad Sci 1028: 258-272.
35. Clemente, C., Caruso, M.G., Berloco, P., Notarnicola, M., D'Attoma, B., Osella, A.R. et al. (1999) Antioxidant effect of short-term hormonal treatment in postmenopausal women, Maturitas 31: 137-142.
36. Crompton, M., Moser, R., Ludi, H. and Carafoli, E. (1978) The interrelations between the transport of sodium and calcium in mitochondria of various mammalian tissues, Eur J Biochem 82: 25-31.
37. Corasaniti, M.T., Amantea, D., Russo, R., Piccirilli, S., Leta, A., Corazzari, M. et al. (2005) 17beta-estradiol reduces neuronal apoptosis induced by HIV-1 gp 120 in the neocortex of rat, Neurotoxicology 26: 893-903.
38. Cruz, J.C. and Tsai, L.H. (2004) A Jekyll and Hyde kinase: roles for Cdk 5 in brain development and disease, Curr Opin Neurobiol 14: 390-94.
39. Culmsee, C., Vedder, H., Ravati, A., Junker, V., Otto, D., Ahlemeyer, B. et al. (1999) Neuroprotection by estrogens in a mouse model of focal cerebral ischemia and in cultured neurons: evidence for a receptor-independent antioxidative mechanism, J Cereb Blood Flow Metab 19: 1263-1269.
40. Davis, J.B. and Maher, P. (1994) Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line, Brain Res 652: 169-173.
41. Deecher, D.C., Daoud, P., Bhat, R.A. and O'Connor, L.T. (2005) Endogenously expressed estrogen receptors mediate neuroprotection in hippocampal cells (HT22), J Cell Biochem 95: 302-312.
42. de Girolamo, L.A., Hargreaves, A.J. and Billett, E.E. (2001) Protection from MPTP-induced neurotoxicity in differentiating mouse N2a neuroblastoma cells, J Neurochem 76: 650-660.
43. de Kosky, S.T., Abrahamson, E.E., Ciallella, J.R., Paljug, W.R., Wisniewski, S.R., Clark, R.S.B. et al. (2007) Association of increased cortical soluble A 42 levels with diffuse plaques after severe brain injury in humans, Arch Neurol 64: 541-544.
44. Demonacos, C.V., Karayanni, N., Hatzoglou, E., Tsiriyiotis, C., Spandidos, D.A. and Sekeris, C.E. (1996) Mitochondrial genes as sites of primary action of steroid hormones, Steroids 61: 226-232.
45. Desmond, D.W., Moroney, J.T., Sano, M. and Stern, Y. (2002) Incidence of dementia after ischemic stroke: results of a longitudinal study, Stroke 33: 2254-2260.
46. de Vries, A.C., Nelson, R.J., Traystman, R.J. and Hurn, P.D. (2001) Cognitive and behavioral assessment in experimental stroke research: will it prove useful?, Neurosci Biobehav Rev 25: 325-342.
47. Dewar, D., Graham, D.I., Teasdale, G.M. and McCulloch, J. (1993) Alz-50 and ubiquitin immunoreactivity is induced by permanent focal cerebral ischaemia in the cat, Acta Neuropathol 86: 623-629.
48. Dicko, A., Morissette, M., Ben Ameur, S., Pézolet, M. and Di Paolo, T. (1999) Effect of estradiol and tamoxifen on brain membranes: investigation by infrared and fluorescence spectroscopy, Brain Res Bull 49: 401-405.
49. Disshon, K.A. and Dluzen, D.E. (1997) Estrogen as a neuromodulator of MPTP-induced neurotoxicity: effects upon striatal dopamine release, Brain Res 764: 9-16.
50. Dluzen, D.E., McDermott, J.L. and Liu, B. (1996) Estrogen alters MPTP-induced neurotoxicity in female mice: effects on striatal dopamine concentrations and release, J Neurochem 66: 658-666.
51. Dluzen, D. and Horstink, M. (2003) Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies, Endocrine 21: 67-75.
52. Dubal, D.B., Kashonm, M.L., Pettigrewm, L.C.J.M., Finklestein, S.P., Rau, S.W. et al. (1998) Estradiol protects against ischemic injury, J Cereb. Blood Flow Metab 18: 1253-1258.
53. Dubal, D.B., Shughrue, P.J., Wilson, M.E., Merchenthaler, I. and Wise, P.M. (1999) Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors, J Neurosci 19: 6385-6393.
54. Dykens, J.A., Simpkins, J.W., Wang, J. and Gordon, K. (2003) Polycyclic phenols, estrogens and neuroprotection: a proposed mitochondrial mechanism, Exp Gerontol 38: 101-107.
55. Espeland, M.A., Rapp, S.R., Shumaker, S.A., Brunner, R., Manson, J.E., Sherwin, B.B. et al. (2004) Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study, J Amer Med Assoc 291: 2959-2968.
56. Feng, Z. and Zhang, J.T. (2005) Long-term melatonin or 17beta-estradiol supplementation alleviates oxidative stress in ovariectomized adult rats, Free Radic Biol Med 39: 195-204.
57. Fillit, H., Weinreb, H., Cholst, I., Luine, V., McEwen, B. Amador, R. et al. (1986) Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type, Psychoneuroendocrinology 11: 337-345.
58. Fitzpatrick, J.L., Mize, A.L., Wade, C.B., Harris, J.A., Shapiro, R.A. and Dorsa, D.M. (2002) Estrogen-mediated neuroprotection against beta-amyloid toxicity requires expressionof estrogen receptor alpha or beta and activation of the MAPK pathway, J Neurochem 82: 674-682.
59. Fukuda, K., Yao, H., Ibayashi, S., Nakahara, T., Uchimura, H., Fujishima, M. et al. (2000) Ovariectomy exacerbates and estrogen replacement attenuates photothrombotic focal ischemic brain injury in rats, Stroke 31: 155-160.
60. Gagné, B., Gélinas, S., Bureau, G., Lagacé, B., Ramassamy, C., Chiasson, K. et al. (2003) Effects of estradiol, phytoestrogens, and Ginkgo biloba extracts against 1-methyl-4-phenylpyridine-induced oxidative stress, Endocrine 21: 89-95.
61. Gélinas, S., Bureau, G., Valastro, B., Massicotte, G., Cicchetti, F., Chiasson, K. et al. (2004) Alpha and beta estradiol protect neuronal but not native PC 12 cells from paraquat-induced oxidative stress, Neurotox Res 6: 141-148.
62. Gollapudi, L. and Oblinger, M.M. (1999) Stable transfection of PC 12 cells with estrogen receptor (ERalpha): protective effects of estrogen on cell survival after serum deprivation, J Neurosci Res 56: 99-108.
63. Goodman, Y., Bruce, A.J., Cheng, B. and Mattson, M.P. (1996) Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons, J Neurochem 66: 1836-1844.
64. Green, P.S., Gridley, K.E. and Simpkins, J.W. (1996) Estradiol protects against beta-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells, Neurosci Lett 218: 165-168.
65. Green, P.S., Bishop, J. and Simpkins, J.W. (1997 a) 17 alpha-estradiol exerts neuroprotective effects on SK-N-SH cells, J Neurosci 17: 511-515.
66. Green, P.S., Gordon, K. and Simpkins, J.W. (1997 b) Phenolic A ring requirement for the neuroprotective effects of steroids, J Steroid Biochem Mol Biol 63: 229-235.
67. Green, P.S., Gridley, K.E. and Simpkins, J.W. (1998) Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione, Neuroscience 84: 7-10.
68. Green, P.S., Bales, K., Paul, S. and Bu, G. (2005) Estrogen therapy fails to alter amyloid deposition in the PDAPP model of Alzheimer's disease, Endocrinology 146: 2774-2781.
69. Green, P.S., Yang, S.H., Nilsson, K.R., Kumar, A.S., Covey, D.F. and Simpkins, J.W. (2001) The nonfeminizing enantiomer of 17beta-estradiol exerts protective effects in neuronal cultures and a rat model of cerebral ischemia, Endocrinology 142: 400-6.
70. Greenfield, J.P., Leung, L.W., Cai, D., Kaasik, K., Gross, R.S., Rodriguez-Boulan, E. et al. (2002) Estrogen lowers Alzheimer beta-amyloid generation by stimulating trans-Golgi network vesicle biogenesis, J Biol Chem 277: 12128-12136.
71. Gridley, K.E., Green, P.S. and Simpkins, J.W. (1998) A novel, synergistic interaction between 17 beta-estradiol and glutathione in the protection of neurons against beta-amyloid 25-35-induced toxicity in vitro, Mol Pharmacol 54: 874-880.
72. Harman, S.M. (2006) Estrogen replacement in menopausal women: recent and current prospective studies, the WHI and the KEEPS, Gend Med 3: 254-269.
73. Hawk, T., Zhang, Y.Q., Rajakumar, G., Day, A.L. and Simpkins, J.W. (1998) Testosterone increases and estradiol decreases middle cerebral artery occlusion lesion size in male rats, Brain Res 796: 296-298.
74. Hawkins, V., Shen, Q. and Chiueh, C.C. (1999) Kynostatin and 17beta-estradiol prevent the apoptotic death of human neuroblastoma cells exposed to HIV-1 protease, J Biomed Sci 6: 433-438.
75. He, Z., He, Y.J., Day, A.L. and Simpkins, J.W. (2002) Proestrus levels of estradiol during transient global cerebral ischemia improves the histological outcome of the hippocampal CA 1 region: perfusion-dependent and-independent mechanisms, J Neurol Sci 193: 79-87.
76. Henderson, V.W., Stanford, C.A., Espeland, M.A., Hogan, P.E., Rapp, S.R., Stefanick, M.L. et al. (2007) Prior use of hormone therapy and incident Alzheimer's disease in the Women's Health Initiative Memory Study. American Academy of Neurology 59th Annual Meeting: Abstract S31.004.
77. Henon, H., Durieu, I., Guerouaou, D., Lebert, F., Pasquier, F. and Leys, D. (2001) Poststroke dementia: incidence and relationship to prestroke cognitive decline, Neurology 57: 1216-1222.
78. Honda, K., Sawada, H., Kihara, T., Urushitani, M., Nakamizo, T., Akaike, A. et al. (2000) Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured cortical neurons, J Neurosci Res 60: 321-327.
79. Honda, K., Shimohama, S., Sawada, H., Kihara, T., Nakamizo, T., Shibasaki, H. et al. (2001) Nongenomic antiapoptotic signal transduction by estrogen in cultured cortical neurons, J Neurosci Res 64: 466-475.
80. Horvat, A., Nikezi, G., Petrovi, S. and Kanazir, D.T. (2001) Binding of estradiol to synaptosomal mitochondria: physiological significance, Cell Mol Life Sci 58: 636-644.
81. Horvat, A., Petrovi, S., Nedeljkovi, N., Martinovi, J.V. and Nikezi, G. (2000) Estradiol affect Na-dependent Ca2+ efflux from synaptosomal mitochondria, Gen Physiol Biophys 19: 59-71.
82. Hosoda, T., Nakajima, H. and Honjo, H. (2001) Estrogen protects neuronal cells from amyloid beta-induced apoptotic cell death, Neuroreport 12: 1965-1970.
83. Howard, S.A., Brooke, S.M. and Sapolsky, R.M. (2001) Mechanisms of estrogenic protection against gp120-induced neurotoxicity, Exp Neurol 168: 385-391.
84. Howell, A., de Friend, D.J., Robertson, J.F., Blamey, R.W., Anderson, L. et al. (1996) Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer, Br J Cancer 74: 300-308.
85. Ikeda, K., Akiyama, H., Arai, T., Kondo, H., Haga, C., Tsuchiya, K. et al. (2000) Neurons containing Alz-50-immunoreactive granules around the cerebral infarction: evidence for the lysosomal degradation of altered tau in human brain?, Neurosci Lett 284: 187-189.
86. Ikonomovic, M.D., Uryu, K., Abrahamson, E.E., Ciallella, J.R., Trojanowski, J.Q., Lee, V.M.-Y. et al. (2004) Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury, Exp Neurol 190: 192-203.
87. Jaffe, A.B., Toran-Allerand, C.D., Greengard, P. and Gandy, S.E. (1994) Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein, J Biol Chem 269: 13065-13068.
88. Jellinger, K.A., Paulus, W., Wrocklage, C. and Litvan, I. (2001) Effects of closed traumatic brain injury and genetic factors on the development of Alzheimer's disease, Eur J Neurol 8: 707-710.
89. Jung, M.E., Rewal, M., Perez, E., Wen, Y. and Simpkins, J.W. (2004) Estrogen protects against brain lipid peroxidation in ethanol-withdrawn rats, Pharmacol Biochem Behav 79: 573-586.
90. Jung, M.E., Wilson, A.M. and Simpkins, J.W. (2006) A nonfeminizing estrogen analog protects against ethanol withdrawal toxicity in immortalized hippocampal cells, J Pharmacol Exp Ther 319: 543-550.
91. Karhunen, H., Pitkanen, A., Virtanen, T., Gureviciene, I., Pussinen, R., Ylinen, A. et al. (2003) Long-term functional consequences of transient occlusion of the middle cerebral artery in rats: a 1-year follow-up of the development of epileptogenesis and memory impairment in relation to sensorimotor deficits, Epilepsy Res 54: 1-10.
92. Kajta, M., Budziszewska, B., Marsza, M. and Laso, W. (2001) Effects of 17-beta estradiol and estriol on NMDA-induced toxicity and apoptosis in primary cultures of rat cortical neurons, J Physiol Pharmacol 52: 437-446.
93. Kawas, C., Resnick, S., Morrison, A., Brookmeyer, R., Corrada, M., Zonderman, A. et al. (1997) A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging, Neurology 48: 1517-1521.
94. Kenchappa, R.S., Diwakar, L., Annepu, J. and Ravindranath, V. (2004) Estrogen and neuroprotection: higher constitutive expression of glutaredoxin in female mice offers protection against MPTP-mediated neurodegeneration, FASEB J 18: 1102-1104.
95. Kendall, S.L., Anderson, C.F., Nath, A., Turchan-Cholewo, J., Land, C.L., Mactutus, C.F. et al. (2005) Gonadal steroids differentially modulate neurotoxicity of HIV and cocaine: testosterone and ICI 182,780 sensitive mechanism, BMC Neurosci 6: 40.
96. Kesavapany, S., Li, B.S., Amin, N., Zheng, Y.L., Grant, P. and Pant, H.C. (2004) Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk 5 inhibitory peptide, Biochim Biophys Acta 1697: 143-153.
97. Kim, H., Bang, O.Y., Jung, M.W., Ha, S.D., Hong, H.S., Huh, K. et al. (2001) Neuroprotective effects of estrogen against beta-amyloid toxicity are mediated by estrogen receptors in cultured neuronal cells, Neurosci Lett 302: 58-62.
98. Kokmen, E., Whisnant, J.P., O'Fallon, W.M., Chu, C.P. and Beard, C.M. (1996) Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984), Neurology 46: 154-159.
99. Kumar, D.M., Perez, E., Cai, Z.Y., Aoun, P., Brun-Zinkernagel, A.M., Covey, D.F. et al. (2005) Role of nonfeminizing estrogen analogues in neuroprotection of rat retinal ganglion cells against glutamate-induced cytotoxicity, Free Radic Biol Med 38: 1152-1163.
100. Kuroki, Y., Fukushima, K., Kanda, Y., Mizuno, K. and Watanabe, Y. (2001) Neuroprotection by estrogen via extracellular signal-regulated kinase against quinolinic acid-induced cell death in the rat hippocampus, Eur J Neurosci 13: 472-476.
101. Law, S.W., Apostolakis, E.M., Samora, P.J., O'Malley, B.W. and Clark, J.H. (1994) Hormonal regulation of hypothalamic gene expression: identification of multiple novel estrogen induced genes, J Steroid Biochem Mol Biol 51: 131-136.
102. Lei, D.L., Long, J.M., Hengemihle, J., O'Neill, J., Manaye, K.F., Ingram, D.K. and Mouton, P.R. (2003) Effects of estrogen and raloxifene on neuroglia number and morphology in the hippocampus of aged female mice, Neuroscience 121: 659-666.
103. Levin-Allerhand, J.A., Lominska, C.E., Wang, J. and Smith, J.D. (2002) 17Alpha-estradiol and 17beta-estradiol treatments are effective in lowering cerebral amyloid-beta levels in AbetaPPSWE transgenic mice, J Alzheimers Dis 4: 449-457.
104. Li, R., Shen, Y., Yang, L.B., Lue, L.F., Finch, C. and Rogers, J. (2000) Estrogen enhances uptake of amyloid beta-protein by microglia derived from the human cortex, J Neurochem 75: 1447-1454.
105. Liang, Y., Belford, S., Tang, F., Prokai, L., Simpkins, J.W. and Hughes, J.A. (2001) Membrane fluidity effects of estratrienes, Brain Res Bull 54: 661-668.
106. Liu, R., Yang, S.H., Perez, E., Yi, K.D., Wu, S.S., Eberst, K. et al. (2002) Neuroprotective effects of a novel non-receptor-binding estrogen analogue: in vitro and in vivo analysis, Stroke 33: 2485-2491.
107. Liu, X., Fan, X.L., Zhao, Y., Luo, G.R., Li, X.P., Li, R. et al. (2005) Estrogen provides neuroprotection against activated microglia-induced dopaminergic neuronal injury through both estrogen receptor-alpha and estrogen receptor-beta in microglia, J Neurosci Res 81: 653-665.
108. Loeb, C., Gandolfo, C., Croce, R. and Conti, M. (1992) Dementia associated with lacunar infarction, Stroke 23: 1225-1229.
109. Maki, P.M., Zonderman, A.B. and Resnick, S.M. (2001) Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy, Am J Psychiatry 158: 227-233.
110. Manson, J.E., Hsia, J., Johnson, K.C., Rossouw, J.E., Assaf, A.R. et al. (2003) Estrogen plus progestin and the risk of coronary heart disease, N Eng J Med 349: 523-534.
111. Markgraf, C.G., Green, E.J., Hurwitz, B.E., Morikawa, E., Dietrich, W.D. et al. (1992) Sensorimotor and cognitive consequences of middle cerebral artery occlusion in rats, Brain Res 575: 238-246.
112. Markgraf, C.G., Green, E.J., Watson, B., McCabe, P.M., Schneiderman, N., Dietrich, W.D. et al. (1994) Recovery of sensorimotor function after distal middle cerebral artery photothrombotic occlusion in rats, Stroke 25: 153-159.
113. Markgraf, C.G., Johnson, M.P., Braun, D.L. and Bickers, M.V. (1997) Behavioral recovery patterns in rats receiving the NMDA receptor antagonist MDL 100,453 immediately post-stroke, Pharmacol Biochem Behav 56: 391-397.
114. Martín, C., Barturen, K., Martínez, R., Lacort, M. and Ruiz-Larrea, M.B. (1998) In vitro inhibition by estrogens of the oxidative modifications of human lipoproteins, J Physiol Biochem 54: 195-202.
115. Mattson, M.P., Robinson, N. and Guo, Q. (1997) Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1, Neuroreport 8: 3817-3821.
116. McManus, J., McEneny, J., Young, I.S. and Thompson, W. (1996) The effect of various oestrogens and progestogens on the susceptibility of low density lipoproteins to oxidation in vitro, Maturitas 25: 125-131.
117. Mendelowitsch, A., Ritz, M.F., Ros, J., Langemann, H. and Gratzl, O. (2001) 17beta-Estradiol reduces cortical lesion size in the glutamate excitotoxicity model by enhancing extracellular lactate: a new neuroprotective pathway, Brain Res 901: 230-236.
118. Mérot, Y., Ferrière, F., Debroas, E., Flouriot, G., Duval, D. and Saligaut, C. (2005) Estrogen receptor alpha mediates neuronal differentiation and neuroprotection in PC 12 cells: critical role of the A / B domain of the receptor, J Mol Endocrinol 35: 257-267.
119. Miller, C.P., Jirkovsky, I., Hayhurst, D.A. and Adelman, S.J. (1996) In vitro antioxidant effects of estrogens with a hindered 3-OH function on the copper induced oxidation of low density lipoprotein, Steroids 61: 305-308.
120. Mitsios, N., Pennucci, R., Krupinski, J., Sanfeliu, C., Gaffney, J., Kumar, P. et al. (2007) Expression of cyclin-dependent kinase 5 mRNA and protein in the human brain following acute ischemic stroke, Brain Pathol 17: 11-23.
121. Monaco, E.A. 3rd and M.L. Vallano (2005) Role of protein kinases in neurodegenerative disease: cyclin-dependent kinases in Alzheimer's disease, Front Biosci 10: 143-159.
122. Mook-Jung, I., Joo, I., Sohn, S., Kwon, H.J., Huh, K. and Jung, M.W. (1997) Estrogen blocks neurotoxic effects of beta-amyloid (1-42) and induces neurite extension on B 103 cells, Neurosci Lett 235: 101-104.
123. Moosmann, B. and Behl, C. (1999) The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties, Proc Natl Acad Sci U S A 96: 8867-8872.
124. Morinaga, A., Hirohata, M., Ono, K. and Yamada, M. (2007) Estrogen has anti-amyloidogenic effects on Alzheimer's beta-amyloid fibrils in vitro, Biochem Biophys Res Commun 359: 697-702.
125. Morkuniene, R., Jekabsone, A. and Borutaite, V. (2002) Estrogens prevent calcium-induced release of cytochrome c from heart mitochondria, FEBS Lett 521: 53-56.
126. Mulnard, R.A., Cotman, C.W., Kawas, C., van Dyck, C.H., Sano, M., Doody, R. et al. (2000) Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study, J Amer Med Assoc 283: 1007-1015.
127. Nakamizo, T., Urushitani, M., Inoue, R., Shinohara, A., Sawada, H., Honda, K. et al. (2000) Protection of cultured spinal motor neurons by estradiol, Neuroreport 11: 3493-3497.
128. Nilsen, J. and Brinton, R.D. (2004) Mitochondria as therapeutic targets of estrogen action in the central nervous system, Curr Drug Targets CNS Neurol Disord 3: 297-313.
129. Nilsen, J. and Brinton, R.D. (2003) Mechanism of estrogen-mediated neuroprotection: regulation of mitochondrial calcium and Bcl-2 expression, Proc Natl Acad Sci USA 100: 2842-2847.
130. Nilsen, J., Irwin, R.W., Gallaher, T.K. and Brinton, R.D. (2007) Estradiol in vivo regulation of brain mitochondrial proteome, J Neurosci. 27: 14069-77.
131. Noteboom, W.D. and Gorski, J. (1965) Stereospecific binding of estrogens in the rat uterus, Arch Biochem Biophys 111: 559-568.
132. Ohkura, T., Isse, K., Akazawa, K., Hamamoto, M., Yaoi, Y. and Hagino, N. (1994) Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type, Endocr J 41: 361-371.
133. Olivieri, G., Novakovic, M., Savaskan, E., Meier, F., Baysang, G., Brockhaus, M. et al. (2002) The effects of beta-estradiol on SHSY5Y neuroblastoma cells during heavy metal induced oxidative stress, neurotoxicity and beta-amyloid secretion, Neuroscience 113: 849-855.
134. Olsson, A., Csajbok, L., Ost, M., Hoöglund, K., Nylén, K., Rosengren, L., Nellgard, B. and Blennow, K. (2004) Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury, J Neurol 251: 870-876.
135. Paganini-Hill, A. and Henderson, V. (1994) Estrogen deficiency and risk of Alzheimer's disease in women, Am J Epidemiol 140: 256-261.
136. Paganini-Hill, A. and Henderson, V.W. (1996) Estrogen replacement therapy and risk of Alzheimer disease, Arch Intern Med 156: 2213-2217.
137. Park, O.J. (2001) Comparison of estrogen and genistein in their antigenotoxic effects, apoptosis and signal transduction protein expression patterns, Biofactors 21: 379-382.
138. Pasquier, F. and Leys, D. (1997) Why are stroke patients prone to develop dementia?, J Neurol 244: 135-142.
139. Perez, E., Liu, R., Yang, S.H., Cai, Z.Y., Covey, D.F. and Simpkins, J.W. (2005) Neuroprotective effects of an estratriene analog are estrogen receptor independent in vitro and in vivo, Brain Res 1038: 216-222.
140. Perez, E., Cai, Z.Y., Covey, D.F. and Simpkins, J.W. (2006) Neuroprotective effects of estratriene analogs: structure-activity relationships and molecular optimization, Drug Development Research 68: 78-92.
141. Petanceska, S.S., Nagy, V., Frail, D. and Gandy, S. (2000) Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain, Neurology 54: 2212-2217.
142. Petrovic, S., Demajo, M. and Horvat, A. (2005) Estradiol affects calcium transport across mitochondrial membrane in different brain regions, Ann N Y Acad Sci 1048: 341-343.
143. Phillips, S.M. and Sherwin, B.B. (1992) Effects of estrogen on memory function in surgically menopausal women, Psychoneuroendocrinology 17: 485-495.
144. Pohjasvaara, T., Mantyla, R., Ylikoski, R., Kaste, M. and Erkinjuntti, T. (2000) Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en Neurosciences, Stroke 31: 2952-2957.
145. Prokai, L., Prokai-Tatrai, K., Perjesi, P., Zharikova, A.D., Perez, E.J., Liu, R. and Simpkins, J.W. (2003) Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection, Proc Natl Acad Sci U S A 100: 11741-11746.
146. Rapp, S.R., Espeland, M.A., Shumaker, S.A., Henderson, V.W., Brunner, R.L., Manson, J.E. et al. (2003) Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial, J Amer Med Assoc 289: 2663-2672.
147. Regan, R.F. and Guo, Y. (1997) Estrogens attenuate neuronal injury due to hemoglobin, chemical hypoxia, and excitatory amino acids in murine cortical cultures, Brain Res 764: 133-140.
148. Resnick, S.M. and Maki, P.M. (2001) Effects of hormone replacement therapy on cognitive and brain aging, Ann N Y Acad Sci 949: 203-214.
149. Resnick, S.M., Maki, P.M., Golski, S., Kraut, M.A. and Zonderman, A.B. (1998) Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance, Horm Behav 34: 171-182.
150. Roman, G.C. (2002) Vascular dementia may be the most common form of dementia in the elderly, J Neurol Sci 203-204: 7-10.
151. Roman, G.C., Erkinjuntti, T., Wallin, A., Pantoni, L. and Chui, H.C. (2002) Subcortical ischaemic vascular dementia, Lancet Neurol 1: 426-436.
152. Roömer, W., Oettel, M., Menzenbach, B., Droescher, P. and Schwarz, S. (1997) Novel estrogens and their radical scavenging effects, iron-chelating, and total antioxidative activities: 17 alpha-substituted analogs of delta 9 (11)-dehydro-17 beta-estradiol, Steroids 62: 688-694.
153. Roof, R.L., Schielke, G.P., Ren, X. and Hall, E.D. (2001) A comparison of long-term functional outcome after 2 middle cerebral artery occlusion models in rats, Stroke 32: 2648-2657.
154. Ruiz-Larrea, M.B., Leal, A.M., Liza, M., Lacort, M. and de Groot, H. (1994) Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes, Steroids 59: 383-388.
155. Ruiz-Larrea, B., Leal, A., Martín, C., Martínez, R. and Lacort, M. (1995) Effects of estrogens on the redox chemistry of iron: a possible mechanism of the antioxidant action of estrogens, Steroids 60: 780-783.
156. Russo, R., Navarra, M., Maiuolo, J., Rotiroti, D., Bagetta, G. and Corasaniti, M.T. (2005) 17beta-estradiol protects SH-SY5Y Cells against HIV-1 gp120-induced cell death: evidence for a role of estrogen receptors, Neurotoxicology 26: 905-13.
157. Sack, M.N., Rader, D.J. and Cannon, R.O. (1994) Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women, Lancet 343: 269-270.
158. Sagara, Y. (1998) Induction of reactive oxygen species in neurons by haloperidol, J Neurochem 71: 1002-1012.
159. Samuelsson, M., Soderfeldt, B. and Olsson, G.B. (1996) Functional outcome in patients with lacunar infarction, Stroke 27: 842-846.
160. Sasaki, K., Sato, M. and Umezawa, Y. (2003) Fluorescent indicators for Akt / protein kinase B and dynamics of Akt activity visualized in living cells, J Biol Chem 278: 30945-30951.
161. Sawada, H., Ibi, M., Kihara, T., Urushitani, M., Akaike, A. and Shimohama, S. (1998) Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death, J Neurosci Res 54: 707-719.
162. Sawada, H., Ibi, M., Kihara, T., Urushitani, M., Honda, K., Nakanishi, M. et al. (2000) Mechanisms of antiapoptotic effects of estrogens in nigral dopaminergic neurons, FASEB J 14: 1202-1214.
163. Schmidt, A.J., Krieg, J.C. and Vedder, H. (2002) Differential effects of glucocorticoids and gonadal steroids on glutathione levels in neuronal and glial cell systems, J Neurosci Res 67: 544-550.
164. Schneider, L.S., Farlow, M.R., Henderson, V.W. and Pogoda, J.M. (1996) Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease, Neurology 46: 1580-1584.
165. Schwenke, D.C., Wagner, J.D. and Adams, M.R. (1999) In vitro lipid peroxidation of LDL from postmenopausal cynomolgus macaques treated with female hormones, J Lipid Res 40: 235-244.
166. Sherwin, B.B. (1997) Estrogen effects on cognition in menopausal women, Neurology 48: S21-S26.
167. Shi, J., Panickar, K.S., Yang, S.H., Rabbani, O., Day, A.L. and Simpkins, J.W. (1998) Estrogen attenuates over-expression of beta-amyloid precursor protein messager RNA in an animal model of focal ischemia, Brain Res 810: 87-92.
168. Shoulson, I. (1998) Experimental therapeutics of neurodegenerative disorders: unmet needs, Science 282: 1072-1074.
169. Shughrue, P.J. (2004) Estrogen attenuates the MPTP-induced loss of dopamine neurons from the mouse SNc despite a lack of estrogen receptors (ERalpha and ERbeta), Exp Neurol. 190: 468-77.
170. Shumaker, S.A., Legault, C., Kuller, L., Rapp, S.R., Thal, L., Lane, D.S. et al. (2004) Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study, J Amer Med Assoc 291: 2947-2958.
171. Shumaker, S.A., Legault, C., Rapp, S.R., Thal, L., Wallace, R.B., Ockene, J.K. et al. (2003) Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial, J Amer Med Assoc 289: 2651-2662.
172. Sierens, J., Hartley, J.A., Campbellm, M.J., Leathem, A.J. and Woodside, J.V. (2001) Effect of phytoestrogen and antioxidant supplementation on oxidative DNA damage assessed using the comet assay, Mutat Res 485: 169-176.
173. Simpkins, J.W., Rajakumar, G., Zhang, Y.Q., Simpkins, C.E., Greenwald, D., Yu, C.J. et al. (1997) Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat, J Neurosurg 87: 724-730.
174. Simpkins, J.W., Yang, S.H., Liu, R., Perez, E., Cai, Z.Y., Covey, D.F. et al. (2004) Estrogen-like compounds for ischemic neuroprotection, Stroke 35(11 Suppl. 1): 2648-2651.
175. Simpkins, J.W., Wang, J., Wang, X., Perez, E., Prokai, L. and Dykens, J.A. (2005 a) Mitochondria play a central role in estrogen-induced neuroprotection, Curr Drug Targets CNS Neurol Disord 4: 69-83.
176. Simpkins, J.W., Wen, Y., Perez, E., Yang, S. and Wang, X. (2005 b) Role of nonfeminizing estrogens in brain protection from cerebral ischemia: an animal model of Alzheimer's disease neuropathology, Ann N Y Acad Sci 1052: 233-242.
177. Simpkins, J.W., Yang, S.H., Wen, Y. and Singh, M. (2005 c) Estrogens, progestins, menopause and neurodegeneration: basic and clinical studies, Cell Mol Life Sci 62: 271-280.
178. Singer, C.A., Rogers, K.L. and Dorsa, D.M. (1998) Modulation of Bcl-2 expression: a potential component of estrogen protection in NT 2 neurons, Neuroreport 9: 2565-2568.
179. Singh, M. and Simpkins, J.W. (2005) The Future of Hormone Therapy: What Basic Science and Clinical Studies Teach Us. New York Academy of Science, New York.
180. Singh, M., Sumien, N., Kyser, C. and Simpkins, J.W. (2008) Estrogens and progesterone as neuroprotectants: what animal models teach us, Front Biosci 13: 1083-1089.
181. Smith, S.E., Hodges, H., Sowinski, P., Man, C.M., Leach, M.J., Sinden, J.D. et al. (1997) Long-term beneficial effects of BW619C89 on neurological deficit, cognitive deficit and brain damage after middle cerebral artery occlusion in the rat, Neuroscience 77: 1123-1135.
182. Solakidi, S., Psarra, A.M., Nikolaropoulos, S. and Sekeris, C.E. (2005) Estrogen receptors alpha and beta (ERalpha and ERbeta) and androgen receptor (AR) in human sperm: localization of ERbeta and AR in mitochondria of the midpiece, Hum Reprod 20: 3481-87.
183. Sortino, M.A., Chisari, M., Merlo, S., Vancheri, C., Caruso, M. and Nicoletti, F. (2004) Glia mediates the neuroprotective action of estradiol on beta-amyloid-induced neuronal death, Endocrinology 145: 5080-5086.
184. Sribnick, E.A., Ray, S.K., Nowak, M.W., Li, L. and Banik, N.L. (2004) 17beta-estradiol attenuates glutamate-induced apoptosis and preserves electrophysiologic function in primary cortical neurons, J Neurosci Res 76: 688-696.
185. Stirone, C., Duckles, S.P., Krausem, D.N. and Procaccio, V. (2005) Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels, Mol Pharmacol 68: 959-965.
186. Stroemer, R.P., Kent, T.A. and Hulsebosch, C.E. (1998) Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with D-amphetamine therapy after neocortical infarction in rats, Stroke 29: 2381-2393.
187. Sudo, S., Wen, T.C., Desaki, J., Matsuda, S., Tanaka, J., Arai, T. et al. (1997) Beta-estradiol protects hippocampal CA 1 neurons against transient forebrain ischemia in gerbil, Neurosci Res 29: 345-354.
188. Sur, P., Sribnick, E.A., Wingrave, J.M., Nowak, M.W., Ray, S.K. and Banik, N.L. (2003) Estrogen attenuates oxidative stress-induced apoptosis in C 6 glial cells, Brain Res 971: 178-188.
189. Takao, T., Flint, N., Lee, L., Ying, X., Merrill, J. and Chandross, K.J. (2004) 17beta-estradiol protects oligodendrocytes from cytotoxicity induced cell death, J Neurochem 89: 660-673.
190. Tamura, A., Graham, D.I., McCulloch, J. and Teasdale, G.M. (1981) Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion, J Cereb Blood Flow Metab 1: 53-60.
191. Tang, M., Abplanalp, W., Ayres, S. and Subbiah, M.T. (1996 a) Superior and distinct antioxidant effects of selected estrogen metabolites on lipid peroxidation, Metabolism 45: 411-414.
192. Tang, M.X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B. et al. (1996 b) Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease, Lancet 348: 429-432.
193. Tatemichi, T.K., Foulkes, M.A., Mohr, J.P., Hewitt, J.R., Hier, D.B., Price, T.R. et al. (1990) Dementia in stroke survivors in the Stroke Data Bank cohort. Prevalence, incidence, risk factors, and computed tomographic findings, Stroke 21: 858-866.
194. Tatemichi, T.K., Paik, M., Bagiella, E., Desmond, D.W., Stern, Y., Sano, M. et al. (1994) Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study, Neurology 44: 1885-1891.
195. Telci, A., Cakatay, U., Akhan, S.E., Bilgin, M.E., Turfanda, A. and Sivas, A. (2002) Postmenopausal hormone replacement therapy use decreases oxidative protein damage, Gynecol Obstet Invest 54: 88-93.
196. Thibodeau, P.A., Kachadourian, R., Lemay, R., Bisson, M., Day, B.J. and Paquette, B. (2002) In vitro pro- and antioxidant properties of estrogens, J Steroid Biochem Mol Biol 81: 227-236.
197. Toung, T.J., Traystman, R.J. and Hurn, P.D. (1998) Estrogen-mediated neuroprotection after experimental stroke in male rats, Stroke 29: 1666-1670.
198. Toung, T.K., Hurn, P.D., Traystman, R.J. and Sieber, F.E. (2000) Estrogen decreases infarct size after temporary focal ischemia in a genetic model of type 1 diabetes mellitus, Stroke 31: 2701-2706.
199. Turchan, J., Anderson, C., Hauser, K.F., Sun, Q., Zhang, J., Liu, Y., Wise, P.M., Kruman, I., Maragos, W., Mattson, M.P., Booze, R. and Nath, A. (2001) Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine, BMC Neurosci 2: 3.
200. van den Heuvel, C., Thornton, E. and Vink, R. (2007) Traumatic brain injury and Alzheimer's disease: a review, Prog Brain Res 161: 303-316.
201. van Itallie, C.M. and Dannies, P.S. (1998) Estrogen induces accumulation of the mitochondrial ribonucleic acid for subunit II of cytochrome oxidase in pituitary tumor cells, Mol Endocrinol 2: 332-337.
202. Vassar, R. (2007) Caspase-3 cleavage of GGA 3 stabilizes BACE: implications for Alzheimer's disease, Neuron 54: 671-673.
203. Vedder, H., Anthes, N., Stumm, G., Wurz, C., Behl, C. and Krieg, J.C. (1999) Estrogen hormones reduce lipid peroxidation in cells and tissues of the central nervous system, J Neurochem 72: 2531-38.
204. Vedder, H., Teepker, M., Fischer, S. and Krieg, J.C. (2000) Characterization of the neuroprotective effects of estrogens on hydrogen peroxide-induced cell death in hippocampal HT 22 cells: time and dose-dependency, Exp Clin Endocrinol Diabetes 108: 120-127.
205. Vegeto, E., Bonincontro, C., Pollio, G., Sala, A., Viappiani, S., Nardi, F. et al. (2001) Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia, J Neurosci 21: 1809-1818.
206. Wallace, D.R., Dodson, S., Nath, A. and Booze, R.M. (2006) Estrogen attenuates gp120- and tat1-72-induced oxidative stress and prevents loss of dopamine transporter function, Synapse 59: 51-60.
207. Wang, X., Simpkins, J.W., Dykens, J.A. and Cammarata, P.R. (2003) Oxidative damage to human lens epithelial cells in culture: estrogen protection of mitochondrial potential, ATP, and cell viability, Invest Ophthalmol Vis Sci 44: 2067-2075.
208. Wang, J., Green, P.S. and Simpkins, J.W. (2001) Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3-nitroproprionic acid in SKN- SH human neuroblastoma cells, J Neurochem 77: 804-811.
209. Wen, Y., Onyewuchi, O., Yang, S., Liu, R. and Simpkins, J.W. (2004 a) Increased beta-secretase activity and expression in rats following transient cerebral ischemia, Brain Res 1009: 1-8.
210. Wen, Y., Yang, S., Liu, R. and Simpkins, J.W. (2004 b) Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein, Brain Res 1022: 30-38.
211. Wen, Y., Yu, W.H., Maloney, B., Bailey, J., Ma, J., Marié, I. et al. (2008) Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing, Neuron 57: 680-690.
212. Whiting, K.P., Restall, C.J. and Brain, P.F. (2000) Steroid hormone-induced effects on membrane fluidity and their potential roles in non-genomic mechanisms, Life Sci 67: 743-757.
213. Winterle, J.S., Mill, T., Harris, T. and Goldbeck, R.A. (2001) Absolute kinetic characterization of 17-beta-estradiol as a radical-scavenging, antioxidant synergist, Arch Biochem Biophys 392: 233-244.
214. Wise, P.M., Dubal, D.B., Wilson, M.E., Rau, S.W., Boöttner, M. and Rosewell, K.L. (2001) Estradiol is a protective factor in the adult and aging brain: understanding of mechanisms derived from in vivo and in vitro studies, Brain Res Brain Res Rev 37: 313-319.
215. Wiseman, H. (1994) The antioxidant action of a pure antioestrogen: ability to inhibit lipid peroxidation compared to tamoxifen and 17 beta-oestradiol and relevance to its anticancer potential, Biochem Pharmacol 47: 493-498.
216. Yang, S.H., He, Z., Wu, S.S., He, Y.J., Cutright, J., Millard, W.J. et al. (2001) 17-beta estradiol can reduce secondary ischemic damage and mortality of subarachnoid hemorrhage, J Cereb Blood Flow Metab 21: 174-181.
217. Yang, S.H., Liu, R., Perez, E.J., Wen, Y., Stevens, S.M. Jr., Valencia, T., Brun-Zinkernagel, A.M. et al. (2004) Mitochondrial localization of estrogen receptor beta, Proc Natl Acad Sci U S A 101: 4130-4135.
218. Yonemori, F., Yamada, H., Yamaguchi, T., Uemura, A. and Tamura, A. (1996) Spatial memory disturbance after focal cerebral ischemia in rats, J Cereb Blood Flow Metab 16: 973-980.
219. Yonemori, F., Yamaguchi, T., Yamada, H. and Tamura, A. (1999) Spatial cognitive performance after chronic focal cerebral ischemia in rats, J Cereb Blood Flow Metab 19: 483-494.
220. Yi, K.D., Chung, J., Pang, P. and Simpkins, J.W. (2005) Role of protein phosphatases in estrogen-mediated neuroprotection, J Neurosci 25: 7191-7198.
221. Yi, K.D., Cai, Z.Y., Covey, D.F. and Simpkins, J.W. (2008) Estrogen receptor-independent neuroprotection via protein phosphatase preservation and attenuation of persistent extracellular signal-regulated kinase 1 / 2 activation, J Pharmacol Exp Ther 324: 1188-1195.
222. Yu, X., Rajala, R.V., McGinnis, J.F., Li, F., Anderson, R.E., Yan, X. et al. (2004) Involvement of insulin / phosphoinositide 3-kinase/Akt signal pathway in 17 beta-estradiolmediated neuroprotection, J Biol Chem 279: 13086-13094.
223. Zandi, P.P., Carlson, M.C., Plassman, B.L., Welsh-Bohmer, K.A., Mayer, L.S., Steffens, D.C. et al. (2002) Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study, J Amer Med Assoc 288: 2123-2129.
224. Zemlyak, I., Brooke, S.M. and Sapolsky, R.M. (2002) Protection against gp120-induced neurotoxicity by an array of estrogenic steroids, Brain Res 958: 272-276.
225. Zemlyak, I., Brooke, S. and Sapolsky, R. (2005) Estrogenic protection against gp 120 neurotoxicity: role of microglia, Brain Res 1046: 130-136.
226. Zhao, L., Wu, T.W. and Brinton, R.D. (2004) Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons, Brain Res 1010: 22-34.
227. Zhao, L., O'Neill, K. and Diaz Brinton, R. (2005) Selective estrogen receptor modulators (SERMs) for the brain: current status and remaining challenges for developing NeuroSERMs, Brain Res Brain Res Rev 49: 472-493.
228. Zhao, L., O'Neill, K. and Brinton, R.D. (2006) Estrogenic agonist activity of ICI 182,780 (Faslodex) in hippocampal neurons: implications for basic science understanding of estrogen signaling and development of estrogen modulators with a dual therapeutic profile, J Pharmacol Exp Ther 319: 1124-32.
229. Zhao, L., Jin, C., Mao, Z., Gopinathan, M.B., Rehder, K. and Brinton, R.D. (2007) Design, synthesis, and estrogenic activity of a novel estrogen receptor modulator - a hybrid structure of 17beta-estradiol and vitamin E in hippocampal neurons, J Med Chem 50: 4471-4481.
230. Zhang, Y. and Bhavnani, B.R. (2005) Glutamate-induced apoptosis in primary cortical neurons is inhibited by equine estrogens via down-regulation of caspase-3 and prevention of mitochondrial cytochrome c release, BMC Neurosci 6: 13.
231. Zheng, J. and Ramirez, V.D. (2000) Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals, Br J Pharmacol 130: 1115-1123.
232. Zheng, J. and Ramirez, V.D. (1999 a) Purification and identification of an estrogen binding protein from rat brain: oligomycin sensitivity-conferring protein (OSCP), a subunit of mitochondrial F0F1-ATP synthase/ATPase, J Steroid Biochem Mol Biol 68: 65-75.
233. Zheng, J. and Ramirez, V.D. (1999 b) Rapid inhibition of rat brain mitochondrial proton F0F1-ATPase activity by estrogens: comparison with Na+, K+ -ATPase of porcine cortex, Eur J Pharmacol 368: 95-102.
234. Zheng, H., Xu, H., Uljon, S.N., Gross, R., Hardy, K., Gaynor, J. et al. (2002) Modulation of A(beta) peptides by estrogen in mouse models, J Neurochem 80: 191-196.